Is there a link between viral hepatitis and lymphoproliferative disorders? from the autopsy room to the PCR thermal cycler

Current Diagnostic Pathology

Volumn 3, Issue 3, 1996, Pages 177-181

  Heimann, R ^a   Lespagnard, L ^a   Dargent, J L ^a   Desmet, V J ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000195491     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(05)80015-8     Document Type: Article

References (47)

1. Mosler F. Die Pathologie und Therapie der Leukämie. Hirschwald, Berlin, 1872, pp. 85-89.
2. Klein S. Ein Fall von Pseudoleukämie nebst Lebercirrhose mit recurrirendem Fieberverlauf Berl Klin Wsch, XXVII;1890; 712-717.
3. Mosse M. lieber metalymphämische Lebercirrhose. Berlin Klin Wsch.XLV 1908; 1219-1221.
4. Rössle R. Entzündungen der Leber. In: F. Henke, O. Lubarsch, (Eds). Handbuch der speziellen pathologischen Anatomie und Histologie. Springer, Berlin 1930; V/I: 242-505.
5. Gruber G B. Die Leber bei Erkrankungen des blut und lymphbildenden Gewebs-Apparates. In: F. Henke, O. Lubarsch (Eds). Handbuch der speziellen pathologischen Anatomie und Histologie. Springer, Berlin 1930; V/I: 631-686.
6. Hässig A. Ueber Lebercirrhose bei Leukämie. Schweiz Z Path Bact 1947; 10: 667-684.
7. Prinz F. Ueber Abbauvorgänge in der Leber bei Leukämie. Virchows Arch 1951; 320: 86-92.
8. Colsky J, Greenspan E M , and Warren T N. Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists. Arch Pathol 1955; 59: 198-206.
9. Wetherley-Mein G, Cottom D G. Portal fibrosis in acute leukaemia. Br J Haematol 1956; 2: 345-354.
10. Doerr W. Der Wandel klassischer Krankheitsbilder unter chemischer und antibiotischer Therapie. Verh dtsch Ges Path 1956; 39: 17-73.
11. Bock H E, Gross R, Lambers K, Wulf G. Leukämie und Leber. Medizinische 1959; 29-30: 1325-1331.
12. Hitzig W H, Schärer K. Lebercirrhose bei Antifolsaürebehandlung akuter paraleukoblastenleukämien. Helv Paediat Acta 1960;15: 235-252.
13. Hutter R V P, Shipkey F H, Tan C T C, Murphy M L, Chowdhury M. Hepatic fibrosis in children with acute leukemia. Cancer 1960; 13: 288-307.
14. Amromin G D, Deliman R M, Shanbrom E. Liver damage after chemiotherapy for leukemia and lymphoma. Gastroenterology 1962; 42:401-410.
15. Fischer R. Neue Aspekte der pathologischen Anatomie der Leukosen. Internist 1968; 9:457-465.
16. Niedobitek F. Fibröse der Leber bei acuter Leukose im Kindesalter. Verh dtsch Ges Path 1968; 52: 553-557.
17. Diebold J, Camilleri J P, Delarue J. Les lésions hépatiques au cours des leucoses. Etude histopathologique. Ann Anal Path 1969; 14:41-56.
18. Fischer R, Schaefer H E. Die pathologischen Anatomie der Leukosen. In: R Gross, J Van De Loo (Eds). Leukämie. Springer, Berlin, Heidelberg, New York 1972; 1-24.
19. Heimann R. Cirrhosis and lymphoproliferative disorders. Lancet ii 1971; 101.
20. Heimann R. Cirrhosis and Lymphoproliferative disorders. Lancet ii 1971; 705.
21. Heimann R. Cirrhoses et lymphopathies malignes. Acta gastroenterol belg 1971; 34: 663-675.
22. Vykoupil K F, Georgii A. Ueber die fibrosierende Wirkung von Lymphozyten in der Leber bei Lymphadenosen. In: H Pietschmann (Ed). Der Lymphozyt, Struktur, Physiologie, Pathologie und Klinik. Wiener Medizinischen Akademie 1972; 199-203.
23. Heimann R, Ray M B , Desmet V J. HBsAg, chronic lymphoproliferative disorders, and cirrhosis of the liver. J Clin Pathol 1977; 30: 817-821.
24. Waldenström J. Clinical diagnosis and biochemical findings in material of 296 sera with M-type, narrow, gamma globulins. Acta Medica Scandinavica 1961; 367 (Suppl): 110-119.
25. Lennert K, Stein H, Kaiserling E. Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer 1975; 31(SuppI II): 29-43.
26. Yoeli M, Bumingham R A, Habib M. A Leukemic lymphoproliferative disease in A/J mice following inoculation with blood from patients with acute infectious hepatitis. Cancer Res 1974;34:3440-3445.
27. Blumberg B S, Sutnick A I, London W T. Hepatitis and leukaemia: their relation to Australia antigen. Bull N Y Acad Med 1968; 44: 1566-1586.
28. Nowoslawski A, Brzosko W J, Madalinski K, Krawczynski K. Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders. Lancet i; 1970:494-498.
29. Naparstek J, Eliakim M. Malignant lymphoproliferative disorders in chronic liver disease. Report of four cases and review of the literature. Digestive Diseases 1978; 23: 887-892.
30. Talamo T S, Dekker A, Gurecki J, Singh G. Primary Hepatic malignant lymphoma: its occurrence in a patient with chronic active hepatitis, cirrhosis and hepatocellular carcinoma associated with hepatitis B viral infection. Cancer 1980; 46: 336-339.
31. Paraf A, Karsenti P, Kemeny F, Richard P. Cirrhosis du foie et 'Lymphomes': cinq nouvelles observations. Ann Med Interne 1980; 131: 235-238.
32. Bettini R, Curzio M, Ferrari V, Rapazzini P. The association of liver cirrhosis and malignant lymphomas. (letter) Haematologica 1985; 70: 376.
33. Cirasino L, Cupella F, Fasani F, Barosi G, Tarsia C. Immunoblastic lymphoma and liver cirrhosis. (letter) Haematologica 1985; 70: 87-88.
34. Lisker-Melman M, Pittalluga S, Pluda J M et al. Primary lymphoma of the liver in a patient with acquired immune deficiency syndrome and chronic hepatitis B. Am J Gastroenterol 1989; 84: 1445-1448.
35. Ohsawa M, Aozasa K, Horiuchi K et al. Malignant lymphoma of the liver. Report of five cases and review of the literature. Dig DisSc 1992; 37: 1105-1109.
36. Ryan J, Wallace S, Jones P, Taggart G, Dudley F. Primary hepatic lymphoma in a patient with chronic hepatitis C. J Gastroenterol Hepatol 1994; 9:308-310.
37. Devars du Mayne J F, Barge J, Damade R, Gaudin B, Legmann P, Cerf M. Lymphome malin primitif du foie et cirrhose: une association inédite. Ann Med Interne 1987; 138: 34-37.
38. Heimann R, Lespagnard L, Desmet V. Pathogenic role of hepatitis B virus (HBV) (letter). Am J Pathol 1995; 147: 223.
39. Fern C, La Civita L, Longombardo G, Greco F, Bombardier S. Hepatitis C virus and mixed cryoglobulinaemia (Review). Eur J Clin Invest 1993; 23: 399-405.
40. Fern C, Monti M, La Civita L et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinaemia. Blood 1993; 82: 3701-3704.
41. Ferri C, Caracciolo F, Zignego A L et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-394.
42. Franzin F, Efremov D G, Pozzato G, Tulissi P, Batista F, Burrone O R. Clonal B-cell expansions in peripheral blood of HCVinfected patients. Br J Haematol 1995; 90: 548-552.
43. Crouzier R, Martin T, Pasquali J L. Monoclonal IgM Rheumatoid factor secreted by CDS-negative B cells during mixed cryoglobulinaemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene. J Immunol 1995:154:413-21.
44. De Vita S, Sansonno D, Dolcetti R et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinaemia. Blood 1995; 86: 1887-1892.
45. Galun E, Ilan Y, Livni N et al. Hepatitis B virus infection associated with hematopoietic tumors. Am J Pathol 1994; 145: 1001-1007.
46. Sing G K, Prior S, Feman A, Cooksley G. Hepatitis B virus differentially suppresses myelopoiesis and displays tropism for immature hematopoietic cells. J Virol 1993; 67: 3454-3460.
47. Tran A, Quaranta J F, Benzaken S et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18:253-257.